בייאטה 5 מק"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

EXENATIDE 250 MCG/ML

MAH:

ASTRA ZENECA ISRAEL LTD

ATC_code:

A10BX04

pharmaceutical_form:

SOLUTION FOR INJECTION

administration_route:

S.C

manufactured_by:

LILLY PHARMA FERT. & DISTRIB. GmbH & Co. KG

therapeutic_group:

EXENATIDE

therapeutic_indication:

Byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.Byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

authorization_date:

2013-01-01